Sort
16,300 grants matching “fatty liver disease”
Copper Homeostasis and Liver Function
$595,143Svetlana Lutsenko · Johns Hopkins University · R01 · FY2024 · DK
Hereditary Genetics of Hepatocellular Carcinoma
$595,097Kirk J Wangensteen · Mayo Clinic Rochester · R37 · FY2024 · CA
IKKepsilon/TBK1 Inhibitors for the Treatment of Obesity and Type 2 Diabetes
$594,912Alan R. Saltiel · University Of Michigan At Ann Arbor · R01 · FY2014 · DK
Lipotoxicity and Maintenance of Metabolic Health
$594,765Jean E Schaffer · Joslin Diabetes Center · R01 · FY2025 · DK
Genetic Architecture of Adiposity in Multiple Large Cohorts
$594,762Ingrid Bernadette Borecki · Washington University · R01 · FY2011 · DK
Core--Laboratory and Data Management
$594,659Ernst John Schaefer · Beth Israel Deaconess Medical Center · P50 · FY2012 · HL
Saturated fatty acids involved in DNA damage response, mediated by IRE1a, to promote chemotolerance
$594,628Christina Chan · Michigan State University · · FY2023 · ENG
Hepatocyte-derived extracellular vesicles in alcoholic liver disease
$594,593Ariel Feldstein · University Of California, San Diego · R01 · FY2020 · AA
A Novel Nanodrug for Metabolic Disease Treatment
$594,547Yu-Jui Yvonne Wan · University Of California At Davis · R56 · FY2024 · DK
Lipotoxicity and Maintenance of Metabolic Health
$594,331Jean E Schaffer · Joslin Diabetes Center · R01 · FY2023 · DK
Role of the Macrophage in Developmentally Programmed NAFLD
$593,946Jacob E Friedman · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2022 · DK
Heat shock protein 90 in alcoholic liver disease: targeting macrophage Function
$593,939Pranoti Mandrekar · Univ Of Massachusetts Med Sch Worcester · R01 · FY2025 · AA
Integrative Physiology of Thyroid Hormone Receptors and Nuclear Receptor Corepressors
$593,554Mitchell A. Lazar · University Of Pennsylvania · R01 · FY2020 · DK
Novel imprint control regions (ICRs) responsive to environmental exposures
$593,510Cathrine Hoyo · North Carolina State University Raleigh · R01 · FY2025 · ES
Synergistic effects of ECM and heterotypic crosstalk on cellular responses in non-alcoholic fatty liver disease
$593,310Salman R Khetani · University Of Illinois At Chicago · R01 · FY2023 · DK
Dysregulated Complement Pathway in Macrophage Reprogramming and Progression of HCC in MASH
$593,042Renumathy Dhanasekaran · Stanford University · R37 · FY2025 · CA
Advancing 3D optical body surface scan technology to assess physiological and psychological effects in highly obese population
$593,040James K Hahn · George Washington University · R01 · FY2021 · DK
IKKepsilon/TBK1 Inhibitors for the Treatment of Obesity and Type 2 Diabetes
$592,999Alan R. Saltiel · University Of California, San Diego · R01 · FY2017 · DK
IKKepsilon/TBK1 Inhibitors for the Treatment of Obesity and Type 2 Diabetes
$592,999Alan R. Saltiel · University Of California, San Diego · R01 · FY2016 · DK
Genetic dissection of tissue-specific roles of a circadian NADPH phosphatase
$592,812Carla B. Green · Ut Southwestern Medical Center · R01 · FY2024 · DK
Genetic dissection of tissue-specific roles of a circadian NADPH phosphatase
$592,812Carla B. Green · Ut Southwestern Medical Center · R01 · FY2025 · DK
Alterations in Post-Receptor Insulin Signaling in Diabetes and Insulin Resistance
$592,643C Ronald Kahn · Joslin Diabetes Center · R01 · FY2025 · DK
Alterations in Post-Receptor Insulin Signaling in Diabetes and Insulin Resistance
$592,618C Ronald Kahn · Joslin Diabetes Center · R01 · FY2022 · DK
Project 2 - Molecular and Cellular Mechanisms of Cardiometabolic Toxicity of VOCs
$592,550Sanjay Srivastava · University Of Louisville · P42 · FY2025 · ES
Covalent Chemistry on Nanosubstrates Enables Molecular Analysis of Purified Extracellular Vesicles in Hepatocellular Carcinoma
$591,788Hsian-Rong Tseng · University Of California Los Angeles · R01 · FY2021 · CA